Corcept Therapeutics Inc. buy Truist Financial Co.
Start price
02.05.24
/
50%
€22.88
Target price
02.05.25
€41.15
Performance (%)
78.37%
Price
03.10.24
€40.81
Summary
This prediction is currently active. With a performance of 78.37% the BUY prediction by Truist_Financial_Co_ is a big success. This prediction currently runs until 02.05.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Corcept Therapeutics Inc. | 3.737% | 3.737% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Truist Financial Co. from $42.00 to $44.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.88
30.09.24
30.09.24
€68.09
30.09.25
30.09.25
-2.55%
03.10.24
03.10.24
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.62
17.06.24
17.06.24
€60.58
17.06.25
17.06.25
53.31%
03.10.24
03.10.24
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€30.31
04.06.24
04.06.24
€59.79
04.06.25
04.06.25
34.64%
03.10.24
03.10.24
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.60
16.02.24
16.02.24
€39.06
16.02.25
16.02.25
80.58%
03.10.24
03.10.24
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.00
06.11.23
06.11.23
€35.38
06.11.24
06.11.24
70.04%
03.10.24
03.10.24